Drug recall
Premarin tablets (conjugated estrogens tablets, USP) 1.25 mg, 100 and 1,000 tablet bottles, Rx only…
FDA recall event 27166 · Class III · McKesson
Key facts
| Event ID | 27166 |
|---|---|
| Recall numbers | D-333-3 |
| Recalling firm | McKesson |
| Product type | Drugs |
| Products | Premarin tablets (conjugated estrogens tablets, USP) 1.25 mg, 100 and 1,000 tablet bottles, Rx only, Manufactured by Ayerst Laboratories Inc., A Wyeth-Ayerst Company, Philadelphia, PA 19101… |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Dissolution failure: by manufacturer (Wyeth) |
| Initiation date | Jun 23, 2003 |
| City | Memphis |
| Country | United States |
| FEI number | 3002568789 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports